Skip to content

Pilot Study Using a Wireless Motility Capsule

Measurement of Whole Gut Transit Time After a Dietary Fiber Treatment Using a Wireless Motility Capsule

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01102894
Enrollment
10
Registered
2010-04-13
Start date
2009-08-31
Completion date
2010-04-30
Last updated
2014-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food Selection

Brief summary

Research suggests dietary fiber may decrease transit time through the gastrointestinal tract. Research studies traditionally use radio-opaque markers to determine gastric emptying, colonic transit, and whole gut transit time. The SmartPill is a single use pill that can be used to determine gastric emptying, colonic transit, and whole gut transit time without requiring X-rays or fecal collections. Previous studies have found radio-opaque markers and the SmartPill detect the similar transit times. The purpose of this pilot study is to determine if the SmartPill can detect a change in transit time using a significant dose of dietary fiber.

Detailed description

The ability of a device to track gastrointestinal transit time, including gastric emptying time, was measured in healthy people consuming low and high fiber diets.

Interventions

DEVICESmartPill

SmartPill

Sponsors

General Mills
CollaboratorINDUSTRY
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy men and women * Age 18 - 65 * Non-smoking * Not taking medication * Non-dieting * BMI 18-30 * English literacy * Ability to swallow the SmartPill

Exclusion criteria

* Do not regularly consume breakfast * Food allergies to ingredients fond in study products * Dislike of hot cereal * BMI \<18 or \>30 * Are not weight stable * Diagnosed with diabetes, cardiovascular, renal, or hepatic disease * Cancer in previous 5 years (except basal cell carinoma of the skin) * Any gastrointestinal disease or condition * Any gastrointestinal surgeries that alter motility * Recent antibiotic usage (\< 6 months) * recent or concurrent participation in an intervention research study * History of drug or alcohol abuse in prior 6 months * Use of laxatives, anti-diarrheal, antacids, or medications which alter motility * Vegetarians * People who eat more than approximately 15 grams of fiber per day * Currently consume fiber supplements * Women who are pregnant or lactating * Women with irregular menstrual cycles

Design outcomes

Primary

MeasureTime frameDescription
Whole Gut Transit Time5 daysThe time required for the SmartPill to travel through the entire gastrointestinal tract and be present in the feces.

Secondary

MeasureTime frameDescription
Gastrointestinal ToleranceDay 4Subjects scored their gastrointestinal tolerance based on 7 questions on a 0-10 scale on day 4 of each treatment period and the sum score was reported. 0 being the best and 10 being the worst. Each question has a value of 1-10 for a total of 70 points as value.
Food Intake DiaryDay 1Total dietary fiber consumed.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from the University of Minnesota via fliers on the St. Paul campus

Pre-assignment details

Exclusion criteria included contraindicated conditions for the SmartPill: dysphasia, gastric bezoars, strictures, fistulas, bowel obstructions, diverticulitis, previous gastrointestinal surgery, implanted electro-mechanical medical devices, and medications shown to influence gastrointestinal transit time.

Participants by arm

ArmCount
Low Fiber and High Fiber
Subjects consume a high fiber cereal along with swallowing the SmartPill device that measures gastrointestinal transit time Subjects also consumed low fiber SmartPill : SmartPill
10
Total10

Baseline characteristics

CharacteristicLow Fiber and High Fiber
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
Age, Continuous24 years
STANDARD_DEVIATION 2
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Whole Gut Transit Time

The time required for the SmartPill to travel through the entire gastrointestinal tract and be present in the feces.

Time frame: 5 days

Population: All participants had their transit time assessed.

ArmMeasureValue (MEAN)Dispersion
High FiberWhole Gut Transit Time22.5 hoursStandard Deviation 14.6
Low FiberWhole Gut Transit Time31.4 hoursStandard Deviation 5.8
Secondary

Food Intake Diary

Total dietary fiber consumed.

Time frame: Day 1

Population: Day 1 of each treatment subjects completed a 24 hour food record to determine baseline dietary fiber intake

ArmMeasureValue (MEAN)Dispersion
High FiberFood Intake Diary14 gStandard Deviation 7.5
Low FiberFood Intake Diary15 gStandard Deviation 7
Secondary

Gastrointestinal Tolerance

Subjects scored their gastrointestinal tolerance based on 7 questions on a 0-10 scale on day 4 of each treatment period and the sum score was reported. 0 being the best and 10 being the worst. Each question has a value of 1-10 for a total of 70 points as value.

Time frame: Day 4

Population: Each participant completed a gastrointestinal tolerance questionnaire during each treatment period.

ArmMeasureValue (MEAN)Dispersion
High FiberGastrointestinal Tolerance9.5 units on a scaleStandard Deviation 1.7
Low FiberGastrointestinal Tolerance6.8 units on a scaleStandard Deviation 1.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026